Clinician Training Program to Integrate Digital CBTI Into Routine Psychotherapy
Launched by STANFORD UNIVERSITY · Apr 12, 2023
Trial Information
Current as of May 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new training program for therapists to help them use a digital tool called cognitive behavioral therapy for insomnia (dCBTi) in their regular mental health services. The goal is to improve how therapists help their patients who struggle with sleep issues, especially those who also have depression or anxiety.
To participate, therapists must be licensed professionals who see patients at least once a week and can treat those experiencing insomnia. Patients eligible for this study are adults aged 18 and older who are receiving regular therapy, want to improve their sleep, and have access to a smartphone or computer. They also need to be able to read, write, and speak in English. Participants can expect to receive personalized therapy that includes this new digital tool aimed at improving their sleep. It's important to note that certain medical conditions or treatments might prevent someone from joining the study, so interested individuals should discuss their eligibility with their therapist.
Gender
ALL
Eligibility criteria
- Therapist Criteria:
- Inclusion Criteria:
- • Licensed mental health clinicians
- • Have a clinical care model that includes seeing patients weekly or biweekly
- • Provide therapy in English
- • Treat patients with depression and/or anxiety
- • Can identify 1-2 patients who are willing to consent to be training cases.
- Exclusion Criteria:
- • Not meeting all of the inclusion criteria
- Patient Criteria:
- Inclusion Criteria:
- • Aged 18+ years old
- • Receive weekly or biweekly therapy from participating study therapist
- • Identify improving sleep as a goal for treatment and experience insomnia (Insomnia Severity Index score greater than or equal to 10)
- • Have daily access to a smartphone, tablet, or computer
- • Can read, write, and speak in English
- Exclusion Criteria:
- • Conditions known to make study treatment less effective (e.g., current chronic medication use known to interfere with sleep, alcohol or substance use disorder, thought disorder)
- • Conditions for which dCBTi is a safety risk (e.g., bipolar disorder, excessive daytime sleepiness)
- • Current psychotherapy for insomnia
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Nicole Gumport, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials